Therefore, we speculate that due to the different molecular biological mechanisms of different cancers, GPRIN1 promotes the malignant behavior of tumors in lung cancer and liver cancer but plays an inhibitory role in gastric cancer. Here, GPRIN1 is linked to cancer.